Zpráva o průběhu klinického hodnocení KDO_DC1311 (EudraCT č. 2014-003388-39) za období od 10.09.2021 do 09.09.2022

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Annual report about the clinical trial KDO_DC1311 (EudraCT No. 2014-003388-39) for the period from 10 Sept 2021 to 09 Sept 2022
Authors	DEMLOVÁ Regina KUBÁTOVÁ Jana
Year of publication	2022
MU Faculty or unit	Faculty of Medicine
Web	KDO_DC1311
Description	The annual report gives the overview of the conduct of the clinical trial „Combined antitumor therapy with ex vivo manipulated dendritic cells producing interleukin-12 in children, adolescents and young adults with progressive, recurrent or primarily metastatic high-risk tumors“. The primary aim of the clinical trial is to study the safety of inovative medicinal product of somatic cell therapy. Masaryk University is the trial sponsor.
Related projects:	Český národní uzel Evropské sítě infrastruktur klinického výzkumu (CZECRIN)